Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
Belum, V.R, Benhuri, B, Postow, M.A, Hellmann, M.D, Lesokhin, A.M, Segal, N.H, Motzer, R.J, Wu, S, Busam, K.J, Wolchok, J.D, Lacouture, M.E
Published in European journal of cancer (1990) (01.06.2016)
Published in European journal of cancer (1990) (01.06.2016)
Get full text
Journal Article
Immune‐related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
Zarbo, A., Belum, V.R., Sibaud, V., Oudard, S., Postow, M.A., Hsieh, J.J., Motzer, R.J., Busam, K.J., Lacouture, M.E.
Published in British journal of dermatology (1951) (01.06.2017)
Published in British journal of dermatology (1951) (01.06.2017)
Get full text
Journal Article
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
Knox, J.J., Barrios, C.H., Kim, T.M., Cosgriff, T., Srimuninnimit, V., Pittman, K., Sabbatini, R., Rha, S.Y., Flaig, T.W., Page, R.D., Beck, J.T., Cheung, F., Yadav, S., Patel, P., Geoffrois, L., Niolat, J., Berkowitz, N., Marker, M., Chen, D., Motzer, R.J.
Published in Annals of oncology (01.06.2017)
Published in Annals of oncology (01.06.2017)
Get full text
Journal Article
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study
Calvo, E, Escudier, B, Motzer, R.J, Oudard, S, Hutson, T.E, Porta, C, Bracarda, S, Grünwald, V, Thompson, J.A, Ravaud, A, Kim, D, Panneerselvam, A, Anak, O, Figlin, R.A
Published in European journal of cancer (1990) (01.02.2012)
Published in European journal of cancer (1990) (01.02.2012)
Get full text
Journal Article
696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial
Choueiri, T.K., Powles, T., Burotto, M., Bourlon, M.T., Zurawski, B., Oyervides Juárez, V.M., Hsieh, J.J., Basso, U., Shah, A.Y., Suarez, C., Hamzaj, A., Barrios, C.H., Richardet, M., Pook, D., Tomita, Y., Escudier, B., Zhang, J., Simsek, B., Apolo, A.B., Motzer, R.J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
711P Nivolumab + ipilimumab (N+I) vs sunitinib (S) for first-line treatment of advanced renal cell carcinoma (aRCC) in CheckMate 214: 4-year follow-up and subgroup analysis of patients (pts) without nephrectomy
Albiges, L., Tannir, N., Burotto, M., McDermott, D.F., Plimack, E.R., Barthélémy, P., Porta, C.G., Powles, T.B., Donskov, F., George, S., Kollmannsberger, C., Gurney, H., Grimm, M-O., Tomita, Y., Castellano Gauna, D., Rini, B.I., Choueiri, T.K., Saggi, S.S., McHenry, M.B., Motzer, R.J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
A phase 3 study (COSMIC-313) of cabozantinib in combination with nivolumab and ipilimumab in patients with previously untreated advanced renal cell carcinoma of intermediate or poor risk
Choueiri, T., Albiges, L., Powles, T., Geng, A., Mohamed, N., Wang, F., Motzer, R.J.
Published in European urology open science (Online) (01.11.2020)
Published in European urology open science (Online) (01.11.2020)
Get full text
Journal Article
Efficacy of cabozantinib vs everolimus in advanced renal cell carcinoma with bone metastases: results from the phase 3 METEOR study
Bracarda, S, Choueiri, T.K, Powles, T, Motzer, R.J, Olencki, T, Frontera, O.A, Oudard, S, Rolland, F, Tomczak, P, Castellano, D, Appleman, L, Drabkin, H, Vaena, D, Milwee, S, Youkstetter, J, Escudier, B
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
501 Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial
George, S, Motzer, R.J, Hammers, H, Redman, B, Kuzel, T, Tykodi, S.S, Plimack, E, Jiang, J, Waxman, I, Rini, B.I
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Overall survival results from the phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma (METEOR)
Schmidinger, M, Motzer, R.J, Powles, T, Escudier, B, Tannir, N.M, Mainwaring, P.N, Rini, B.I, Hammers, H.J, Donscov, F, Roth, B, Peltola, K, Lee, J.L, Heng, D.Y.C, Aftab, D.T, Hessel, C, Scheffold, C, Schwab, G, Pal, S, Hutson, T.E, Choueiri, T.K
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
Effect of prior systemic therapy on clinical outcomes with cabozantinib vs everolimus in advanced renal cell carcinoma: Results from the phase 3 METEOR study
Grande, E, Choueiri, T.K, Motzer, R.J, Escudier, B, Pal, S, Kollmannsberger, C, Pikiel, J, Gurney, H, Rha, S.Y, Park, S.H, Geertsen, P.F, Gross Goupil, M, Suarez, C, Arroyo, A, Dean, M, George, D, Powles, T
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
Assessment of progression-free survival as a surrogate end-point for overall survival in patients with metastatic renal cell carcinoma
Négrier, S, Bushmakin, A.G, Cappelleri, J.C, Korytowsky, B, Sandin, R, Charbonneau, C, Michaelson, M.D, Figlin, R.A, Motzer, R.J
Published in European journal of cancer (1990) (01.07.2014)
Published in European journal of cancer (1990) (01.07.2014)
Get full text
Journal Article
359 Correlation of tumour-associated macrophage, but not tumour-infiltrating lymphocyte, levels with progression-free survival in patients with metastatic renal cell carcinoma treated with axitinib
Williams, J.A, Martini, J.F, Escudier, B, Rini, B.I, Motzer, R.J, Tarazi, J, Li, S, English, P.A
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
2622 A Phase I/II study to assess the safety and efficacy of pazopanib (paz) and pembrolizumab (pembro) in patients (pts) with advanced renal cell carcinoma (aRCC)
McDermott, D.F, Infante, J.R, Chowdhury, S, Voss, M.H, Motzer, R.J, Perini, R.F, Morosky, A, Zheng, F.F, White, B.C, Wang, Q, Jewell, R.C, Rini, B.I
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
3LBA CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)
Sharma, P, Escudier, B, McDermott, D.F, George, S, Hammers, H.J, Srinivas, S, Tykodi, S.S, Sosman, J.A, Procopio, G, Plimack, E.R, Castellano, D, Gurney, H, Donskov, F, Bono, P, Wagstaff, J, Gauler, T.C, Ueda, T, Xu, L.A, Waxman, I.M, Motzer, R.J
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
1141 POSTER Neutropenia and Thrombocytopenia During Treatment as Biomarkers of Sunitinib Efficacy in Patients With Metastatic Renal Cell Carcinoma (mRCC)
Donskov, F, Cams, A, Barrios, C.H, Escudier, B, Li, S, Perkins, J, Motzer, R.J
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Predicting Outcome to Chemotherapy in Patients With Germ Cell Tumors: The Value of the Rate of Decline of Human Chorionic Gonadotrophin and Alpha-Fetoprotein During Therapy
MAZUMDAR, M, BAJORIN, D. F, BACIK, J, HIGGINS, G, MOTZER, R. J, BOSL, G. J
Published in Journal of clinical oncology (01.05.2001)
Published in Journal of clinical oncology (01.05.2001)
Get full text
Journal Article